| abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to drugs, and concerns combined antiaggregant and antioxidant containing acetylsalicylic acid as an active base, differing by the fact that the active base additionally contains Thiotriazoline. n EFFECT: combined drug exhibits more evident antiaggregant and antioxidant action and provides lower frequency rate of manifested undesired effects of prolonged pharmacotherapy. n 2 cl, 1 dwg, 7 tbl, 3 ex |